These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The utility of dried blood spot monitoring of branched-chain amino acids for maple syrup urine disease: A retrospective chart review study. Kaur J, Nagy L, Wan B, Saleh H, Schulze A, Raiman J, Inbar-Feigenberg M. Clin Chim Acta; 2020 Jan; 500():195-201. PubMed ID: 31678570 [Abstract] [Full Text] [Related]
16. Maple syrup urine disease: favourable effect of early diagnosis by newborn screening on the neonatal course of the disease. Simon E, Fingerhut R, Baumkötter J, Konstantopoulou V, Ratschmann R, Wendel U. J Inherit Metab Dis; 2006 Aug; 29(4):532-7. PubMed ID: 16817013 [Abstract] [Full Text] [Related]
17. Maple syrup urine disease: further evidence that newborn screening may fail to identify variant forms. Puckett RL, Lorey F, Rinaldo P, Lipson MH, Matern D, Sowa ME, Levine S, Chang R, Wang RY, Abdenur JE. Mol Genet Metab; 2010 Jun; 100(2):136-42. PubMed ID: 20307994 [Abstract] [Full Text] [Related]
18. Diagnosis of MSUD by newborn screening allows early intervention without extraneous detoxification. Heldt K, Schwahn B, Marquardt I, Grotzke M, Wendel U. Mol Genet Metab; 2005 Apr; 84(4):313-6. PubMed ID: 15781191 [Abstract] [Full Text] [Related]